Privacy Act, Exempt Record System; Withdrawal

This Rule document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder


DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 21
[Docket No. FDA-2011-N-0252]
Office of the Secretary
45 CFR Part 5b

Privacy Act, Exempt Record System; Withdrawal

Agency

Office of the Secretary, Food and Drug Administration, HHS.

Action

Direct final rule; withdrawal.

Summary

The Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) are withdrawing the direct final rule that August 28, 2012. HHS/FDA published the direct final rule to exempt scientific research misconduct proceedings records from certain requirements of the Privacy Act of 1974 in order to protect records compiled in the course of misconduct inquiries and investigations, and to safeguard the identity of confidential sources. The comment period closed on November 13, 2012. HHS/FDA is withdrawing the direct final rule because the Agency received significant adverse comment.

Dates

Effective Date: The direct final rule published at 77 FR 51910, August 28, 2012, is withdrawn effective January 10, 2013.

For Further Information Contact

Frederick Sadler, Division of Freedom of Information, Food and Drug Administration, 12420 Parklawn Dr., Rockville, MD 20857, 301-796-8975, .

Supplementary Information

HHS and FDA are withdrawing the direct final rule that published in the Federal Register of Tuesday, August 28, 2012 (77 FR 51910). HHS/FDA published the direct final rule to exempt scientific research misconduct proceedings records from certain requirements of the Privacy Act of 1974 in order to protect records compiled in the course of misconduct inquiries and investigations, and to safeguard the identity of confidential sources. The comment period closed on November 13, 2012. HHS/FDA is withdrawing the direct final rule because the Agency received significant adverse comment.

Authority

Therefore, under 5 U.S.C. 552a, the direct final rule published on Tuesday, August 28, 2012, 77 FR 51910, is withdrawn.

Dated: January 10, 2013.

Approved:

Kathleen Sebelius
Secretary, Department of Health and Human Services.
[FR Doc. 2013-00723 Filed 1-10-13; 4:15 pm]
BILLING CODE 4160-01-P
 
 
Comment Period Closed
ID: FDA-2011-N-0252-0003
View original printed format:
PDF

Document Information

Date Posted: Jan 14, 2013
RIN: Not Assigned
CFR: 21 CFR Part 21
Federal Register Number: 2013-00723
Show More Details  

Comments

0
Comments Received*

Docket Information

This document is contained in

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.

Document text and images courtesy of the
Federal Register